SPTXSeaport Therapeutics, Inc.vs its industry peers
A metric-by-metric comparison of Seaport Therapeutics, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SPTXThis | $1.2B#8 | — | 2.8x#5 | — | — | — | — | 0.0%#1 | — | — | — | — |
| AVBP | $1.4B#1 | — | 3.7x#7 | — | — | -106.6%#11 | — | -45.3%#8 | — | — | 52.3%#4 | — |
| ORIC | $1.3B#2 | — | 3.4x#6 | — | — | -1.3%#5 | — | -34.0%#7 | -40.4%#4 | — | 15.1%#7 | — |
| HROW | $1.3B#3 | — | 84.4x#11 | 4.7x#4 | 36.4%#1 | 70.6%#3 | 11.2%#1 | -33.8%#6 | 13.2%#2 | 6#1 | -20.2%#8 | — |
| RARE | $1.3B#4 | — | — | 1.9x#1 | 20.2%#3 | -1.1%#4 | -79.5%#4 | — | — | — | -56.3%#10 | — |
| OMER | $1.3B#5 | 10.0x#1 | — | 17.0x#5 | -34.0%#5 | 97.9%#1 | -166.4%#5 | — | -151.8%#6 | — | 328.7%#3 | — |
| AKTS | $1.2B#6 | — | 2.5x#4 | — | — | — | — | 0.0%#1 | — | — | 23319.4%#1 | — |
| OPK | $1.2B#7 | — | 1.0x#1 | 2.0x#2 | -14.9%#4 | -324.0%#12 | -19.3%#3 | -19058.1%#11 | -13.3%#3 | 4#2 | 16.2%#6 | — |
| ANRO | $1.2B#9 | — | 5.4x#9 | — | — | -2.9%#6 | — | -28.8%#4 | — | — | 664.8%#2 | — |
| MNKD | $1.1B#10 | — | — | 3.3x#3 | 22.2%#2 | -78.7%#8 | 11.1%#2 | — | 2283.8%#1 | — | -33.8%#9 | — |
| MLTX | $1.1B#11 | — | 2.5x#3 | — | — | -91.1%#10 | — | -53.1%#9 | -491.6%#7 | — | — | — |
| JBIO | $1.1B#12 | — | 2.4x#2 | — | — | -83.0%#9 | — | -29.0%#5 | — | — | — | — |
| SVRA | $1.1B#13 | — | 7.4x#10 | 4109.2x#6 | — | -23.9%#7 | -48072.8%#6 | -82.7%#10 | -93.6%#5 | — | 41.8%#5 | — |
| CRVS | $1.0B#14 | — | 4.6x#8 | — | — | 75.4%#2 | — | -6.8%#3 | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-09-17.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice